Using Mitochondrial DNA Mutations to Understand Limitations of Mitochondrial Quality Control
Using Mitochondrial DNA Mutations to Understand Limitations of Mitochondrial Quality Control
批准号:
10397796
负责人:
Evgeni Mikhailovich Frenkel
金额:
$7.05万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2022-04-30
关键词:
AffectAgeAgingAnimal ModelAutophagocytosisBirthCell Culture SystemCell Culture TechniquesCellsComplexDNA SequenceDNA biosynthesisDNA sequencingDataDefectDegenerative DisorderDevelopmentDiseaseDrug resistanceFrequenciesGene ExchangesGoalsLibrariesMammalian CellMeasurableMeasuresMediatingMethodsMitochondriaMitochondrial DNAMitochondrial DiseasesModernizationMutagenesisMutationNatureOrganellesPathologicPathway interactionsPredispositionPrevalenceProcessQuality ControlRecoverySystemTissuesWorkcell typeexperimental studyfollow-upgene productheteroplasmyimprovedmitochondrial DNA mutationmitochondrial autophagymitochondrial dysfunctionmitochondrial genomenovel strategiesresponsesegregation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Mitochondrial DNA (mtDNA) mutations accumulate with age and are present at pathological levels in affected
tissues of certain mitochondrial disorders and degenerative diseases (reviewed in [1, 2]). mtDNA mutations are
susceptible to mitochondrial quality control, the process of selective autophagy of defective mitochondria, as
evidenced by observations that stimulation of mitochondrial autophagy can reduce levels of these mutations in
model organisms [3-6] and cell culture [7, 8] and that defects in mitochondrial quality control correlate with
increased levels of mtDNA mutations [1, 2, 9]. However, the susceptibility of mtDNA to quality control is poorly
understood because it is influenced by multiple complex processes, including the varied sensitivity of quality
control to different types of defects in mtDNA gene products, the exchange of gene products between
organelles through fission and fusion, the impact of mutations on mtDNA replication, and stochasticity of
mtDNA turn-over and inheritance.
The proposed work seeks to understand how the nature of different mtDNA mutations determines
whether they tend to increase or decrease in frequency within the cell (this frequency is known as the level of
heteroplasmy). To do this, I have developed a simple cell culture system that enables the experimenter to tune
the mtDNA mutation rate and copy number per cell, as shown in preliminary data. Using this system, I am
generating a library of cells, each containing one or few new mtDNA mutations present at intermediate
frequency within the cell. Changes in intracellular frequencies of mutations in response to different treatments,
particularly autophagy stimulation, can then be tracked using DNA sequencing. Experiments to elucidate
mechanisms mediating these changes take advantage of greatly improved methods of mitochondrial
purification recently developed in the Sabatini Lab. The specific aims are: I) To elucidate the prevalence and
mechanisms of mtDNA mutations that bias mtDNA replication. II) To understand how mitochondrial quality
control acts on different types of mtDNA mutations.
The key novelty of the approach is to measure changes in frequency of many different kinds of mtDNA
mutations in high throughput. Prior studies focused on a small set of mutations corresponding to drug
resistance markers or relatively-common mitochondrial diseases [12, 13]. In contrast, the goal here is to obtain
similar data for thousands of mutations in a single cell type, approaching saturation-level mutagenesis of the
~16.5kb mammalian mitochondrial genome. The proposed work aims to elucidate the factors limiting efficiency
of mitochondrial quality control with respect to diverse forms of mtDNA-encoded mitochondrial dysfunction.
Understanding these limitations may suggest what renders cells more or less prone to the decline of
mitochondrial function in aging, degenerative disease and mtDNA disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using Mitochondrial DNA Mutations to Understand Limitations of Mitochondrial Quality Control
-
批准号:9895597
-
项目类别:
-
资助金额:$6.74万
-
财政年份:2018
-
负责人:Evgeni Mikhailovich Frenkel
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: